Valuation: Sartorius Stedim Biotech

Market Cap 17.53B 20B 16.21B 14.9B 28.16B 1,930B 28.59B 194B 75.91B 945B 75.14B 73.49B 3,250B P/E 2026 *
45.8x
P/E 2027 * 36x
Enterprise Value 19.55B 22.3B 18.07B 16.61B 31.39B 2,152B 31.87B 216B 84.62B 1,053B 83.77B 81.92B 3,624B EV / Sales 2026 *
6.18x
EV / Sales 2027 * 5.52x
Free-Float
28.47%
Yield 2026 *
0.47%
Yield 2027 * 0.57%
1 day-2.96%
1 week-1.69%
Current month-0.77%
1 month+10.35%
3 months-4.50%
6 months-12.65%
Current year-14.19%
1 week 179.9
Extreme 179.9
190.8
1 month 160.4
Extreme 160.4
190.8
Current year 150
Extreme 150
224
1 year 150
Extreme 150
224
3 years 139.1
Extreme 139.1
287.8
5 years 139.1
Extreme 139.1
551
10 years 50.13
Extreme 50.13
551
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Date Insider Type Main position Quantity % Market Cap.
12/17/25 SellCompany 750,000 0.7706%
2/16/24 Buy

Chief Executive Officer

1,716,739 1.8624%
3/2/22 SellCompany 200,442 0.2174%
Change 5-day change 1-year change 3-year change Capi.($)
-2.96%-1.69%-5.33%-24.16% 20.68B
+0.97%+8.23%-17.80%-5.24% 175B
+0.11%-0.69%-7.05%-3.29% 106B
-1.27%+0.18%+3.80%+58.38% 59.91B
+0.66%+0.96%+37.64%+54.22% 51.95B
-2.33%+1.67%-13.63%-39.40% 43.58B
-2.29%-5.26% - - 33.65B
-1.25%+0.97%-9.77%-43.36% 29.58B
-1.65%-0.39%+67.06%-8.64% 25.31B
-1.55%-0.71%-4.93%-5.70% 21.23B
Average -1.16%+1.56%+5.55%-1.91% 56.77B
Weighted average by Cap. -0.37%+2.70%-2.04%+2.26%

Financials

2026 *2027 *
Net sales 3.17B 3.61B 2.93B 2.69B 5.08B 348B 5.16B 34.96B 13.7B 171B 13.57B 13.27B 587B 3.5B 3.99B 3.23B 2.97B 5.61B 385B 5.7B 38.6B 15.13B 188B 14.98B 14.65B 648B
Net income 380M 434M 351M 323M 610M 41.85B 620M 4.2B 1.65B 20.48B 1.63B 1.59B 70.47B 475M 542M 439M 404M 763M 52.29B 774M 5.25B 2.06B 25.59B 2.04B 1.99B 88.05B
Net Debt 2.01B 2.3B 1.86B 1.71B 3.23B 222B 3.28B 22.23B 8.71B 108B 8.62B 8.44B 373B 1.77B 2.02B 1.63B 1.5B 2.84B 195B 2.88B 19.53B 7.65B 95.27B 7.58B 7.41B 328B
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,456
Date Price Change Volume
26-07-20 €180.20 -2.96% 55,079
26-07-17 €185.70 -0.91% 107,069
26-07-16 €187.40 -0.85% 65,344
26-07-15 €189.00 +0.27% 52,185
26-07-14 €188.50 -0.42% 69,084
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
185.70EUR
Average target price
232.21EUR
Spread / Average Target
+25.05%

Quarterly revenue - Rate of surprise